'Fast Money' traders on how to play Sarepta after report FDA asked it to stop gene therapy shipments

uh Bono and I mean I think Angelica brings up some pretty pertinent points. It seems like really the trust issue might be with management sort of the way they've made their decisions about what to disclose and not and when. Yeah.I mean I think this is the perfect storm of when financial distress meets lack of management oversight. Right. Underscoring everything when you're making an investment is credibility and transparency.And they squarely have dropped the ball on both of those. I still don't quite under ...